Head of the Central Bank of Armenia sees no reason to panic over the depreciation of the dram

YEREVAN, June 5. /ARКА/. In the current situation in Armenia, there is no reason to panic over the depreciation of the dram, says Martin Galstyan, head of the Central Bank of Armenia.

“The Central Bank should neither artificially strengthen nor weaken the exchange rate,” he said on the Rearrange podcast.

Galstyan believes it is best for the exchange rate to be determined by the market, not the Central Bank.

“The exchange rate should be based on supply and demand in the market, and the Central Bank should focus on its job—price stability, not exchange rate stability—because the exchange rate is a tool for ensuring macroeconomic and external balance,” he explained.

According to Armstat, in May 2026, the average settlement exchange rate of the Armenian dram to the US dollar was 368.5 drams, compared to 386.6 drams in May 2025. The 0.8% decline in consumer prices recorded in Armenia in the reporting month compared to April of the same year was accompanied by a 1.5% reduction in the exchange rate of the Armenian dram against the US dollar (the dram strengthened).

spot_img

POPULAR

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

“Unisport” Competes in the UEFA Futsal Champions League

Unisport Futsal Club, established with the sponsorship of Unibank, will host UEFA Futsal Champions League 2026/27 preliminary round matches in Yerevan on August 26, 27 and 29.

LATEST NEWS

spot_imgspot_imgspot_img